Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In Niger, epidemic meningococcal meningitis is primarily caused by Neisseria meningitidis (Nm) serogroup A. However, since 2002, Nm serogroup W135 has been considered to be a major threat that has not yet been realized, and an unprecedented incidence of Nm serogroup X (NmX) meningitis was observed in 2006. METHODS: Meningitis surveillance in Niger is performed on the basis of reporting of clinically suspected cases. Cerebrospinal fluid specimens are sent to the reference laboratory in Niamey, Niger. Culture, latex agglutination, and polymerase chain reaction are used whenever appropriate. Since 2004, after the addition of a polymerase chain reaction-based nonculture assay that was developed to genogroup isolates of NmX, polymerase chain reaction testing allows for the identification of Nm serogroup A, Nm serogroup B, Nm serogroup C, NmX, Nm serogroup Y, and Nm serogroup W135. RESULTS: From January to June 2006, a total of 4185 cases of meningitis were reported, and 2905 cerebrospinal fluid specimens were laboratory tested. NmX meningitis represented 51% of 1139 confirmed cases of meningococcal meningitis, but in southwestern Niger, it represented 90%. In the agglomeration of Niamey, the reported cumulative incidence of meningitis was 73 cases per 100,000 population and the cumulative incidence of confirmed NmX meningitis was 27.5 cases per 100,000 population (74.6 cases per 100,000 population in children aged 5-9 years). NmX isolates had the same phenotype (X : NT : P1.5), and all belonged to the same sequence type (ST-181) as the NmX isolates that were circulating in Niamey in the 1990s. Nm serogroup W135 represented only 2.1% of identified meningococci. CONCLUSIONS: This is, to our knowledge, the first report of such a high incidence of NmX meningitis, although an unusually high incidence of NmX meningitis was also observed in the 1990s in Niamey. The increasing incidence of NmX meningitis is worrisome, because no vaccine has been developed against this serogroup. Countries in the African meningitis belt must prepare to face this potential new challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A high incidence of serogroup X disease was recently reported for Niger, representing 51% of 1,139 confirmed cases of meningococcal meningitis in 2006 (36).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833 · cited 1×
“A relevant selection of Nm isolates that had been collected during the meningitis epidemic season were sent to the World Health Organization’s Collaborating Centre for Reference and Research on Meningococci (Le Pharo, Marseilles, France) for serogroup confirmation, serotyping, and further determination, including mult…”
MethodBulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
mlstdbNet – distributed multi-locus sequence typing (MLST) databases
Jolley, K. A., Chan, M.-S., & Maiden, M. C. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-86 · Cited by 501 · cited 1×
“This publication made use of the Neisseria Multi Locus Sequence Typing website [26] developed by Keith Jolley and Man-Suen Chan and sited at the University of Oxford [29].”
MethodPCR for capsular typing of Haemophilus influenzae
Falla, T. J., Crook, D. W., Brophy, L. N., Maskell, D., Kroll, J. S., & Moxon, E. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.10.2382-2386.1994 · Cited by 413
Meningococcal meningitis in Africa
Greenwood, B. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90106-2 · Cited by 358
Cerebrospinal meningitis in Africa.
Lapeyssonnie, L. (1963) · Europe PMC (PubMed Central) · Cited by 321
Taha, M.-K. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.855-857.2000 · Cited by 260 · cited 2×
“For genogrouping of Nm-positive specimens, a second PCR is performed to amplify the siaD gene for Nm serotypes B, C, Y, and W135, and the open reading frame 2 of the mynB gene for NmA [16].”
MethodSelf-citationEpidemiology of bacterial meningitis in Niamey, Niger, 1981-96.
Campagne, G., Schuchat, A., Djibo, S., Ousseini, A., Cissé, L., & Chippaux, J. (1999) · Europe PMC (PubMed Central) · Cited by 182
Self-citationGarcía, P., García, J., García, E., & López, R. (1986) · Gene · doi:10.1016/0378-1119(86)90215-5 · Cited by 168
Chatelet, I. P. D., Traore, Y., Gessner, B. D., Antignac, A., Naccro, B., Njanpop-Lafourcade, B.-M., Ouedraogo, M. S., Tiendrebeogo, S. R., Varon, E., & Taha, M. K. (2005) · Clinical Infectious Diseases · doi:10.1086/426436 · Cited by 158 · cited 6×
“In 2002, the first epidemic ever identified in Africa as being caused by Nm serogroup W135 occurred in Burkina Faso [9] [10], and the risk of a rapid spread of the epidemic within the meningitis belt was considered to be high.”
BackgroundInfluentialSelf-citationProspective Study of a Serogroup XNeisseria meningitidisOutbreak in Northern Ghana
Gagneux, S., Hodgson, A., Smith, T. A., Wirth, T., Ehrhard, I., Morelli, G., Genton, B., Binka, F. N., Achtman, M., & Pluschke, G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339010 · Cited by 125
Nicolas, P., Norheim, G., Garnotel, É., Djibo, S., & Caugant, D. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5129-5135.2005 · Cited by 115
Self-citationOutbreaks of serogroup X meningococcal meningitis in Niger 1995–2000
Djibo, S., Nicolas, P., Alonso, J. ‐., Djibo, A., Couret, D., Riou, J. ‐., & Chippaux, J. ‐. (2003) · Tropical Medicine & International Health · doi:10.1046/j.1360-2276.2003.01126.x · Cited by 94 · cited 4×
“The lower mean age of patients with NmX meningitis, compared with that of patients with NmA meningitis, was not observed in the 1990s in Niamey [7]; however, at that time, the series of observations was smaller.”
BackgroundResultInfluentialSelf-citationThe duality of virulence and transmissibility in Neisseria meningitidis
Taha, M., Deghmane, A., Antignac, A., Zarantonelli, L., Larribe, M., & Alonso, J. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02402-2 · Cited by 89
Self-citationTraoré, Y., Njanpop‐Lafourcade, B., Adjogble, K., Lourd, M., Yaro, S., Nacro, B., Drabo, A., du Châtelet, I. P., Mueller, J. E., Taha, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507339 · Cited by 84 · cited 1×
“The large meningitis epidemic caused by Nm serogroup W135 belonging to the hypervirulent colonal complex ST-11 in Burkina Faso was not followed by an extension of the epidemic within the African meningitis belt [27].”
BackgroundSelf-citationEpidemic group C meningococcal meningitis in Upper Volta, 1979.
Broome, C. V., Rugh, M. A., Yada, A., Giat, L., Giat, H., Zeltner, J. M., Sanborn, W. R., & Fraser, D. W. (1983) · Europe PMC (PubMed Central) · Cited by 83
Chanteau, S., Sidikou, F., Djibo, S., Moussa, A., Mindadou, H., & Boisier, P. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.09.006 · Cited by 61 · cited 1×
“Since 2002, a PCR assay has been used for the diagnosis of the 3 main etiologies of acute bacterial meningitis in Niger: Nm, Streptococcus pneumoniae, and Haemophilus influenzae b, as described elsewhere [13, 14].”
MethodSelf-citationNew Rapid Diagnostic Tests for Neisseria meningitidis Serogroups A, W135, C, and Y
Chanteau, S., Dartevelle, S., Mahamane, A. E., Djibo, S., Boisier, P., & Nato, F. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030337 · Cited by 55
Self-citationPolymerase Chain Reaction Assay and Bacterial Meningitis Surveillance in Remote Areas, Niger
Sidikou, F., Djibo, S., Taha, M. K., Alonso, J. M., Djibo, A., Kairo, K. K., Chanteau, S., & Boisier, P. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0911.030462 · Cited by 49 · cited 1×
“Since 2002, a PCR assay has been used for the diagnosis of the 3 main etiologies of acute bacterial meningitis in Niger: Nm, Streptococcus pneumoniae, and Haemophilus influenzae b, as described elsewhere [13, 14].”
MethodSelf-citationTzeng, Y., Noble, C., & Stephens, D. S. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.6712-6720.2003 · Cited by 45 · cited 1×
“For the NmX PCR protocol, 2 primers were designed in the serogroup X capsule biosynthesis (xcbA) gene, 1 of the xcbABC cluster of 3 genes that are unique to NmX and were confirmed to be essential for NmX capsule expression [19].”
MethodAjello, G. W., FEELEY, J. C., Hayes, P. S., Reingold, A. L., BOLAN, G. A., Broome, C. V., & Phillips, C. J. (1984) · Journal of Clinical Microbiology · doi:10.1128/jcm.20.1.55-58.1984 · Cited by 43 · cited 1×
“An aliquot of each CSF sample or each Trans-Isolate medium [15] supernatant is freezethawed, boiled for 5 min and centrifuged at 10,000 g for 10 min.”
MethodCarriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?
MacLennan, J. M., Urwin, R., Obaro, S., Griffiths, D., Greenwood, B. M., & Maiden, M. C. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02734-3 · Cited by 41
Clonal Groupings in Serogroup XNeisseria meningitidis
Gagneux, S., Wirth, T., Hodgson, A., Ehrhard, I., Morelli, G., Kriz, P., Genton, B., Smith, T., Binka, F. N., Pluschke, G., et al. (2002) · Emerging infectious diseases · doi:10.3201/eid0805.010227 · Cited by 37 · cited 1×
“lower virulence than usual epidemic strains of NmA [22].”
Background[Resistance to insecticides in the major malaria vectors and its operational importance].
Hamon, J., & Garrett-Jones, C. (1963) · Bulletin of the World Health Organization · Cited by 29
[Resistance to insecticides in the major malaria vectors and its operational importance].
Hamon, J., & Garrett-Jones, C. (1963) · PubMed · Cited by 25
[Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger)].
Étienne, J., Sperber, G., Adamou, A., & Picq, J. J. (1990) · PubMed · Cited by 25
Koumaré, B., Bougoudogo, F., Cissé, M. F., Doumbia, T., & Keïta, M. (1993) · PubMed · Cited by 20
[Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger)].
Étienne, J., Sperber, G., Adamou, A., et al. (1990) · PubMed · Cited by 18
Research works printed but not linked: 10
- Koumare B, Bougoudogo F, Cisse M, Doumbia T, Keita MM. Bacte- riological aspects of purulent meningitis in Bamako district: a propos of 1541 bacterial strains collected from 1979 to 1991 [in French]. Bull Soc Pathol Exot 1993; 86:136-40.
- 1993, Bulletin de la Soci t de pathologie exotique (1990), 86, 136
- Gagneux SP, Hodgson A, Smith TA, et al. Prospective study of a se- rogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis 2002; 185:618-26.
- Parent du Chatelet I, Traore Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain re- action testing. Clin Infect Dis 2005; 40:17-25.
- World Health Organization. Meningococcal disease, serogroup W135, Burkina Faso: preliminary report, 2002. Wkly Epidemiol Rec 2002; 77: 152-5.
- World Health Organization (WHO). Enhanced surveillance of epi- demic meningococcal meningitis in Africa: a three-year experience. Wkly Epidemiol Rec 2005; 80:313-20.
- 2002, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 77, 152
- 2005, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 80, 313
- Multi Disease Surveillance Centre (MDSC). Epidemiological situation of week 22 to 26, 2006. MDSC Meningitis Weekly Bulletin. Ouaga- dougou: World Health Organization-Regional Office for Africa, 2006.
- Traore Y, Njanpop-Lafourcade BM, Adjogble KL, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 2006; 43:817-22.
Cited by
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
“A high incidence of serogroup X disease was recently reported for Niger, representing 51% of 1,139 confirmed cases of meningococcal meningitis in 2006 (36).”
BackgroundGlobal epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Neisseria meningitidis: Biology, Microbiology, and Epidemiology
Rouphael, N. G., & Stephens, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-346-2_1 · Cited by 425
Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404
Meningococcal carriage and disease—Population biology and evolution
Caugant, D. A., & Maiden, M. C. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.061 · Cited by 381
Metadata
- Authors
- Boisier, P., Nicolas, P., Djibo, S., Taha, M.-K., Jeanne, I., Mainassara, H. B., Tenebray, B., Kairo, K. K., Giorgini, D., & Chanteau, S.
- Affiliations
- Centre de Recherche Médicale et Sanitaire (NE)
- World Health Organization (CH)
- Institut Pasteur (FR)
- Ministère de la Santé Publique (NE)
- Corresponding author
- Boisier, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 44
- Issue
- 5
- Pages
- 657-663
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2159099211
- Cited by
- 237
- References
- 26
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 12 · 2017: 12 · 2016: 15 · 2015: 14 · 2014: 21 · 2013: 23 · 2012: 34
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- World Health Organization
- Wellcome Trust
- University of Oxford
- European Commission
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- meningococcal meningitis, serogroup W135, epidemic meningitis, meningitis incidence, Niger, Niamey, serogroup replacement, children aged 5-9 years
- MeSH terms
- Disease Outbreaks, Humans, Meningitis, Meningococcal, Neisseria meningitidis, Niger, Serotyping, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.